Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
2001 1
2010 1
2011 1
2012 1
2017 1
2020 1
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
Miller TM, Cudkowicz ME, Genge A, Shaw PJ, Sobue G, Bucelli RC, Chiò A, Van Damme P, Ludolph AC, Glass JD, Andrews JA, Babu S, Benatar M, McDermott CJ, Cochrane T, Chary S, Chew S, Zhu H, Wu F, Nestorov I, Graham D, Sun P, McNeill M, Fanning L, Ferguson TA, Fradette S; VALOR and OLE Working Group. Miller TM, et al. N Engl J Med. 2022 Sep 22;387(12):1099-1110. doi: 10.1056/NEJMoa2204705. N Engl J Med. 2022. PMID: 36129998 Free article. Clinical Trial.
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study.
Granit V, Benatar M, Kurtoglu M, Miljković MD, Chahin N, Sahagian G, Feinberg MH, Slansky A, Vu T, Jewell CM, Singer MS, Kalayoglu MV, Howard JF Jr, Mozaffar T; MG-001 Study Team. Granit V, et al. Lancet Neurol. 2023 Jul;22(7):578-590. doi: 10.1016/S1474-4422(23)00194-1. Lancet Neurol. 2023. PMID: 37353278 Clinical Trial.
Mycotic keratitis in Paraguay.
Miño de Kaspar H, Zoulek G, Paredes ME, Alborno R, Medina D, Centurion de Morinigo M, Ortiz de Fresco M, Aguero F. Miño de Kaspar H, et al. Among authors: paredes me. Mycoses. 1991 May-Jun;34(5-6):251-4. doi: 10.1111/j.1439-0507.1991.tb00653.x. Mycoses. 1991. PMID: 1795722
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS.
Benatar M, Zhang L, Wang L, Granit V, Statland J, Barohn R, Swenson A, Ravits J, Jackson C, Burns TM, Trivedi J, Pioro EP, Caress J, Katz J, McCauley JL, Rademakers R, Malaspina A, Ostrow LW, Wuu J; CReATe Consortium. Benatar M, et al. Neurology. 2020 Jul 7;95(1):e59-e69. doi: 10.1212/WNL.0000000000009559. Epub 2020 May 8. Neurology. 2020. PMID: 32385188 Free PMC article.
Neuropharmacological profile of ethnomedicinal plants of Guatemala.
Morales Cifuentes C, Gómez-Serranillos MP, Iglesias I, Villar del Fresno AM, Morales C, Paredes ME, Cáceres A. Morales Cifuentes C, et al. Among authors: paredes me. J Ethnopharmacol. 2001 Aug;76(3):223-8. doi: 10.1016/s0378-8741(01)00235-5. J Ethnopharmacol. 2001. PMID: 11448542
FES Bike Race preparation to Cybathlon 2016 by EMA team: a short case report.
Guimarães JA, da Fonseca LO, de Sousa AC, Paredes MEG, Brindeiro GA, Bó APL, Fachin-Martins E. Guimarães JA, et al. Among authors: paredes meg. Eur J Transl Myol. 2017 Dec 5;27(4):7169. doi: 10.4081/ejtm.2017.7169. eCollection 2017 Dec 5. Eur J Transl Myol. 2017. PMID: 29299225 Free PMC article.
Evidence of bacterial biofilms in nasal polyposis.
Zernotti ME, Angel Villegas N, Roques Revol M, Baena-Cagnani CE, Arce Miranda JE, Paredes ME, Albesa I, Paraje MG. Zernotti ME, et al. Among authors: paredes me. J Investig Allergol Clin Immunol. 2010;20(5):380-5. J Investig Allergol Clin Immunol. 2010. PMID: 20945603 Free article.
[Primary Healthcare in Paraguay: overview and prospects].
Dullak R, Rodriguez-Riveros MI, Bursztyn I, Cabral-Bejarano MS, Ruoti M, Paredes ME, Wildberger C, Molinas F. Dullak R, et al. Among authors: paredes me. Cien Saude Colet. 2011 Jun;16(6):2865-75. doi: 10.1590/s1413-81232011000600024. Cien Saude Colet. 2011. PMID: 21709983 Free article. Spanish.
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
Benatar M, Hansen T, Rom D, Geist MA, Blaettler T, Camu W, Kuzma-Kozakiewicz M, van den Berg LH, Morales RJ, Chio A, Andersen PM, Pradat PF, Lange D, Van Damme P, Mora G, Grudniak M, Elliott M, Petri S, Olney N, Ladha S, Goyal NA, Meyer T, Hanna MG, Quinn C, Genge A, Zinman L, Jabari D, Shoesmith C, Ludolph AC, Neuwirth C, Nations S, Shefner JM, Turner MR, Wuu J, Bennett R, Dang H, Sundgreen C; ORARIALS-01 trial team. Benatar M, et al. Lancet Neurol. 2024 May 20:S1474-4422(24)00134-0. doi: 10.1016/S1474-4422(24)00134-0. Online ahead of print. Lancet Neurol. 2024. PMID: 38782015